Near channel low
Consistently delivered good results.
Least PE among Healthcare stocks.
PEG < 1
Good ICR , Low debt
ROE, ROCE better than industry compatriots
Excellent Sales and profit growth
Expecting breakout if good to great results
Consistently delivered good results.
Least PE among Healthcare stocks.
PEG < 1
Good ICR , Low debt
ROE, ROCE better than industry compatriots
Excellent Sales and profit growth
Expecting breakout if good to great results
Transaction en cours:
NH, Back into channel.
Mar 2024
NSE:NH
QOQ
👉Revenue rose 6.23% to 1279cr
👉Profit rose 1.60% to 191cr
👉EPS rose 1.41% to 9.33
👉EBITDA rose 5.73% to 295
👉EBITDA Margin drops 0.00% BPS to 23%
YOY
👉Revenue rose 4.66% from 1222cr
👉Profit rose 10.40% from 173cr
👉EPS rose 10.15% from 8.47
👉EBITDA rose 6.88% from 276
👉EBITDA Margin drops 0.00% BPS from 23%
Fundamentals
👉Stock Price is 1296.3( as of 3/31/2024)
👉Stock PE is 33.57
👉Stock EPS is 38.62
👉Dividend Announced of Rs.4
Growth
👉2 Year Revenue CAGR is 16.48%
👉2 Year Profit CAGR is 51.98%
👉2 Year EPS CAGR is 51.94%
👉2 Year Price CAGR is 31.46%"""